• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Herbalife Ltd.

    5/6/26 11:18:37 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care
    Get the next $HLF alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    HERBALIFE LTD

    (Name of Issuer)


    COMMON STOCK

    (Title of Class of Securities)




    G4412G101

    (CUSIP Number)
    03/31/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    G4412G101


    1Names of Reporting Persons

    FMR LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    5,427,344.40
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    5,448,134.21
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,448,134.21
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.3 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP Number(s):
    G4412G101


    1Names of Reporting Persons

    Abigail P. Johnson
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    5,448,134.21
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,448,134.21
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.3 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    HERBALIFE LTD
    (b)Address of issuer's principal executive offices:

    P.O. BOX 309GT,Ugland House, South Church Street,Georgetown,E9,KY1-1104
    Item 2. 
    (a)Name of person filing:

    FMR LLC
    (b)Address or principal business office or, if none, residence:

    245 Summer Street, Boston, Massachusetts 02210
    (c)Citizenship:

    Not applicable
    (d)Title of class of securities:

    COMMON STOCK
    (e)CUSIP Number(s):

    G4412G101
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    5448134.21
    (b)Percent of class:

    5.3  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    Please see the responses to Items 5 and 6 on the cover page.

     (ii) Shared power to vote or to direct the vote:

    0.00

     (iii) Sole power to dispose or to direct the disposition of:

    5448134.21

     (iv) Shared power to dispose or to direct the disposition of:

    0.00

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of HERBALIFE LTD. No one other person's interest in the COMMON STOCK of HERBALIFE LTD is more than five percent of the total outstanding COMMON STOCK.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See attached Exhibit 99.
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    FMR LLC
     
    Signature:Richard Bourgelas
    Name/Title:Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
    Date:05/05/2026
     
    Abigail P. Johnson
     
    Signature:Richard Bourgelas
    Name/Title:Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of Abigail P. Johnson*
    Date:05/05/2026

    Comments accompanying signature:  *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on April 29,2026, accession number: 0000315066-26-000738.
    Exhibit Information

    Please see Exhibit 99 for 13d-1(k) (1) agreement.

    Get the next $HLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLF

    DatePrice TargetRatingAnalyst
    1/6/2026$20.00Buy
    Maxim Group
    11/26/2025Hold → Buy
    Argus
    3/21/2025$7.50 → $14.00Neutral → Buy
    DA Davidson
    8/1/2024$16.00 → $17.00Buy
    B. Riley Securities
    9/14/2023$13.50Neutral
    DA Davidson
    6/7/2023$13.00Neutral
    Mizuho
    2/3/2023$14.00Underperform
    BofA Securities
    7/12/2022$26.00Hold → Buy
    Jefferies
    More analyst ratings

    $HLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Herbalife Named to Three 2026 USA TODAY Most Trusted Brands Lists

    Recognitions reflect consumer confidence in the company's quality, reliability, and wellness leadership across generations Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, has been named to three 2026 USA TODAY Most Trusted Brands lists, including Most Trusted Brands, Brands Most Trusted by Parents, and Brands Most Trusted by Senior Citizens. The recognitions reflect consumer confidence in Herbalife's science-backed products and commitment to supporting healthy, active lifestyles across generations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603147461/en/Herbalife Named to Three

    6/3/26 4:30:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Chief Financial Officer to Present at East Coast IDEAS Conference on June 11

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, will present at the East Coast IDEAS Conference on Thursday, June 11, 2026 at 10:35 a.m. ET (7:35 a.m. PT). The live webcast will be available at the following link: https://event.summitcast.com/view/GAjb2PfaSPbv9ViGy3AtzN/ZC5vwyKUXDsTKS4G6iXFet A link to the webcast will also be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will be available at the same website following the completion of the event and for six months thereafter. Additional information regarding th

    6/2/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Roman DBDR Acquisition Corp. II Appoints Hunter Gary to Board of Directors and Al Basseri as Chief Technology Officer, Ahead of Proposed Business Combination with ThomasLloyd Climate Solutions

    Roman DBDR Acquisition Corp. II ("Roman DBDR" or the "Company") (NASDAQ:DRDB) today announced the appointment of Hunter Gary to its Board of Directors (the "Board") and Al Basseri as Chief Technology Officer, as the Company continues preparations to complete its previously announced business combination with ThomasLloyd Climate Solutions B.V. ("ThomasLloyd"), a vertically integrated sustainable energy and technology solutions provider (the "Proposed Business Combination"). "We are thrilled to welcome Hunter to the Board of Directors and Al as our Chief Technology Officer as we prepare to complete our business combination with ThomasLloyd," said Dixon Doll, Jr., Chairman and CEO of Roman D

    5/15/26 8:00:00 AM ET
    $AEP
    $CVI
    $DRDB
    Electric Utilities: Central
    Utilities
    Integrated oil Companies
    Energy

    $HLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on Herbalife Nutrition with a new price target

    Maxim Group initiated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $20.00

    1/6/26 9:08:50 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by Argus

    Argus upgraded Herbalife Nutrition from Hold to Buy

    11/26/25 7:50:23 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by DA Davidson with a new price target

    DA Davidson upgraded Herbalife Nutrition from Neutral to Buy and set a new price target of $14.00 from $7.50 previously

    3/21/25 8:38:07 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $HLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $HLF
    SEC Filings

    View All

    Amendment: New insider Walsh Des claimed ownership of 50,000 shares (SEC Form 3)

    3/A - HERBALIFE LTD. (0001180262) (Issuer)

    5/20/26 8:49:59 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Chief Operating Officer Hicks Troy sold $619,556 worth of shares (48,377 units at $12.81), exercised 83,270 shares at a strike of $9.31 and covered exercise/tax liability with 72,626 shares, decreasing direct ownership by 80% to 9,706 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/20/26 8:50:19 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Chief Commercial Officer Lamberti Frank sold $1,932,259 worth of shares (142,919 units at $13.52), decreasing direct ownership by 80% to 36,624 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/12/26 9:59:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Cloud Lynda bought $152,490 worth of shares (17,000 units at $8.97), increasing direct ownership by 78% to 38,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/20/25 8:41:01 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    6/9/25 6:00:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/23/25 4:01:25 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 144 filed by Herbalife Ltd.

    144 - HERBALIFE LTD. (0001180262) (Subject)

    5/11/26 4:12:44 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HERBALIFE LTD. (0001180262) (Filer)

    5/6/26 4:28:47 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 10-Q filed by Herbalife Ltd.

    10-Q - HERBALIFE LTD. (0001180262) (Filer)

    5/6/26 4:23:43 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Leadership Updates

    Live Leadership Updates

    View All

    Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq

    Transaction accelerates Herbalife and Cristiano Ronaldo's commitment to scale personalized nutrition and wellness globally Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced an agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company focused on making health more accessible and actionable. The transaction advances Herbalife's vision of becoming a technology-enabled, data-driven health and wellness platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326423343/en/Herbalife to Expand Its Personalized Nutritional Supplement Capabilit

    3/26/26 6:30:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Welcomes Lynda Cloud to its Board of Directors

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

    4/25/25 5:12:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints Stephan Gratziani as Chief Executive Officer

    Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

    2/19/25 4:05:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/14/24 4:11:11 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G filed by Herbalife Ltd.

    SC 13G - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 4:01:31 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 12:49:27 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Financials

    Live finance-specific insights

    View All

    Herbalife Reports First Quarter 2026 Net Sales Growth and Adjusted EBITDA1 Above Guidance; Raises Full-Year 2026 Constant Currency2 Net Sales and Adjusted EBITDA1 Guidance Midpoints

    Q1 Results in Line with Preliminary Results Announced on April 14 Herbalife Ltd. (NYSE:HLF) today reported financial results for the first quarter ended March 31, 2026: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506758807/en/ "We delivered strong Q1 results that exceeded guidance and we successfully completed our debt refinancing. At the same time, we took further strategic actions to build on Herbalife's deep-rooted strength in personalization, enhance speed to market capabilities, and position us for long-term growth and value creation." - Stephan Gratziani, CEO Highlights First Quarter 2026 Net sales of $1.3

    5/6/26 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Provides Preliminary Q1 2026 Results: Net Sales Above Guidance, Adjusted EBITDA1 Expected At or Above High End of Guidance; Provides Update on Senior Secured Debt Refinancing Plans

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced preliminary first quarter 2026 results. The Company expects: Net sales growth of 7.5% to 8.0% year-over-year, exceeding the high end of previously issued first quarter guidance Net sales growth on a constant currency basis2 of 5.0% to 5.5% year-over-year, above the high end of previously issued first quarter guidance; and Adjusted EBITDA¹ on a reported basis at or above the high end of previously issued first quarter guidance First quarter 2026 guidance for each metric was previously issued on February 18, 2026. The Company's first quarter net sales outperformance was driv

    4/14/26 8:00:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce First Quarter 2026 Results on May 6

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its first quarter 2026 financial results after the close of trading on the NYSE on Wednesday, May 6, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/udjduiru Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BIe9234

    4/1/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care